<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000999'>Pyoderma</z:hpo> gangrenosum (PG) is an inflammatory ulcerative condition of unknown etiology </plain></SENT>
<SENT sid="1" pm="."><plain>An autoimmune mechanism including immune complex-mediated neutrophilic vascular reactions has been suggested </plain></SENT>
<SENT sid="2" pm="."><plain>The role of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) in PG remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Evidence supports the idea that TNF plays a role in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> and migration of neutrophils to these lesions </plain></SENT>
<SENT sid="4" pm="."><plain>PG is frequently associated with various diseases, but up to 50% of cases are idiopathic </plain></SENT>
<SENT sid="5" pm="."><plain>There are several reports describing the successful use of infliximab (Remicade, Centocor, Inc, Horsham, Pa), a chimeric antitumor <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha monoclonal antibody, in the treatment of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>- associated PG, but there have been few reported cases of infliximab in the treatment of idiopathic PG </plain></SENT>
<SENT sid="6" pm="."><plain>The authors present a dramatic improvement in 4 cases of idiopathic PG of the lower leg treated with infliximab </plain></SENT>
</text></document>